End-Stage Renal Disease Drugs Market
1 Study Coverage
1.1 End-Stage Renal Disease (ESRD) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Calcium Succinate
1.2.3 Mk-3866
1.2.4 Pacritinib
1.2.5 Sanguinate
1.2.6 Tesidolumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ICU
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global End-Stage Renal Disease (ESRD) Drugs Sales by Region
2.4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2017-2022)
2.4.2 Global Sales End-Stage Renal Disease (ESRD) Drugs by Region (2023-2028)
2.5 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region
2.5.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2017-2022)
2.5.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers
3.1.1 Global Top End-Stage Renal Disease (ESRD) Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of End-Stage Renal Disease (ESRD) Drugs in 2021
3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers
3.2.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by End-Stage Renal Disease (ESRD) Drugs Revenue in 2021
3.3 Global End-Stage Renal Disease (ESRD) Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Type
4.1.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Sales by Type (2017-2022)
4.1.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
4.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type
4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
4.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Type
4.3.1 Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2017-2022)
4.3.2 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Application
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Sales by Application (2017-2022)
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
5.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application
5.2.1 Global End-Stage Renal Disease (ESRD) Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
5.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Application
5.3.1 Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2017-2022)
5.3.2 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Type
6.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
6.1.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
6.2 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Application
6.2.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
6.2.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
6.3 North America End-Stage Renal Disease (ESRD) Drugs Market Size by Country
6.3.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
6.3.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Type
7.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
7.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
7.2 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Application
7.2.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
7.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
7.3 Europe End-Stage Renal Disease (ESRD) Drugs Market Size by Country
7.3.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
7.3.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Type
8.1.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Application
8.2.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Market Size by Region
8.3.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Type
9.1.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
9.1.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
9.2 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Application
9.2.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
9.2.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
9.3 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size by Country
9.3.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
9.3.2 Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Type
10.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Application
10.2.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size by Country
10.3.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CTI BioPharma Corp
11.1.1 CTI BioPharma Corp Corporation Information
11.1.2 CTI BioPharma Corp Overview
11.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CTI BioPharma Corp Recent Developments
11.2 Merck & Co Inc
11.2.1 Merck & Co Inc Corporation Information
11.2.2 Merck & Co Inc Overview
11.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Inc Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Prolong Pharmaceuticals LLC
11.4.1 Prolong Pharmaceuticals LLC Corporation Information
11.4.2 Prolong Pharmaceuticals LLC Overview
11.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Prolong Pharmaceuticals LLC Recent Developments
11.5 VESSL Therapeutics Ltd
11.5.1 VESSL Therapeutics Ltd Corporation Information
11.5.2 VESSL Therapeutics Ltd Overview
11.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 VESSL Therapeutics Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 End-Stage Renal Disease (ESRD) Drugs Industry Chain Analysis
12.2 End-Stage Renal Disease (ESRD) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 End-Stage Renal Disease (ESRD) Drugs Production Mode & Process
12.4 End-Stage Renal Disease (ESRD) Drugs Sales and Marketing
12.4.1 End-Stage Renal Disease (ESRD) Drugs Sales Channels
12.4.2 End-Stage Renal Disease (ESRD) Drugs Distributors
12.5 End-Stage Renal Disease (ESRD) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 End-Stage Renal Disease (ESRD) Drugs Industry Trends
13.2 End-Stage Renal Disease (ESRD) Drugs Market Drivers
13.3 End-Stage Renal Disease (ESRD) Drugs Market Challenges
13.4 End-Stage Renal Disease (ESRD) Drugs Market Restraints
14 Key Findings in The Global End-Stage Renal Disease (ESRD) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Calcium Succinate
Table 3. Major Manufacturers of Mk-3866
Table 4. Major Manufacturers of Pacritinib
Table 5. Major Manufacturers of Sanguinate
Table 6. Major Manufacturers of Tesidolumab
Table 7. Major Manufacturers of Others
Table 8. Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 11. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2017-2022)
Table 12. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 13. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2023-2028)
Table 14. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2017-2022)
Table 16. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2023-2028)
Table 18. Global End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Manufacturers (2017-2022)
Table 20. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2017-2022)
Table 22. End-Stage Renal Disease (ESRD) Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2021)
Table 25. End-Stage Renal Disease (ESRD) Drugs Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Offered
Table 27. Date of Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 30. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 31. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2017-2022)
Table 32. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2023-2028)
Table 33. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2017-2022)
Table 36. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2023-2028)
Table 37. End-Stage Renal Disease (ESRD) Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 40. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 41. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2017-2022)
Table 42. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2023-2028)
Table 43. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Application (2017-2022)
Table 46. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Application (2023-2028)
Table 47. End-Stage Renal Disease (ESRD) Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 50. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 51. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 54. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 55. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 58. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 59. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 109. CTI BioPharma Corp Corporation Information
Table 110. CTI BioPharma Corp Description and Major Businesses
Table 111. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. CTI BioPharma Corp Recent Developments
Table 114. Merck & Co Inc Corporation Information
Table 115. Merck & Co Inc Description and Major Businesses
Table 116. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Merck & Co Inc Recent Developments
Table 119. Novartis AG Corporation Information
Table 120. Novartis AG Description and Major Businesses
Table 121. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis AG Recent Developments
Table 124. Prolong Pharmaceuticals LLC Corporation Information
Table 125. Prolong Pharmaceuticals LLC Description and Major Businesses
Table 126. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Prolong Pharmaceuticals LLC Recent Developments
Table 129. VESSL Therapeutics Ltd Corporation Information
Table 130. VESSL Therapeutics Ltd Description and Major Businesses
Table 131. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. VESSL Therapeutics Ltd Recent Developments
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. End-Stage Renal Disease (ESRD) Drugs Distributors List
Table 137. End-Stage Renal Disease (ESRD) Drugs Customers List
Table 138. End-Stage Renal Disease (ESRD) Drugs Market Trends
Table 139. End-Stage Renal Disease (ESRD) Drugs Market Drivers
Table 140. End-Stage Renal Disease (ESRD) Drugs Market Challenges
Table 141. End-Stage Renal Disease (ESRD) Drugs Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Product Picture
Figure 3. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Type in 2021 & 2028
Figure 3. Calcium Succinate Product Picture
Figure 4. Mk-3866 Product Picture
Figure 5. Pacritinib Product Picture
Figure 6. Sanguinate Product Picture
Figure 7. Tesidolumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Application in 2021 & 2028
Figure 10. Hospital
Figure 11. Clinic
Figure 12. ICU
Figure 13. Others
Figure 14. End-Stage Renal Disease (ESRD) Drugs Report Years Considered
Figure 15. Global End-Stage Renal Disease (ESRD) Drugs Sales 2017-2028 (K Pcs)
Figure 16. Global End-Stage Renal Disease (ESRD) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Revenue 2017-2028 (US$ Million)
Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2017-2022)
Figure 20. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2023-2028)
Figure 21. North America End-Stage Renal Disease (ESRD) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America End-Stage Renal Disease (ESRD) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe End-Stage Renal Disease (ESRD) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe End-Stage Renal Disease (ESRD) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America End-Stage Renal Disease (ESRD) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa End-Stage Renal Disease (ESRD) Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The End-Stage Renal Disease (ESRD) Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of End-Stage Renal Disease (ESRD) Drugs in the World: Market Share by End-Stage Renal Disease (ESRD) Drugs Revenue in 2021
Figure 33. Global End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
Figure 40. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
Figure 42. North America End-Stage Renal Disease (ESRD) Drugs Sales Share by Country (2017-2028)
Figure 43. North America End-Stage Renal Disease (ESRD) Drugs Revenue Share by Country (2017-2028)
Figure 44. U.S. End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Canada End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
Figure 48. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
Figure 50. Europe End-Stage Renal Disease (ESRD) Drugs Sales Share by Country (2017-2028)
Figure 51. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Share by Country (2017-2028)
Figure 52. Germany End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. France End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Italy End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Russia End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales Share by Region (2017-2028)
Figure 62. Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue Share by Region (2017-2028)
Figure 63. China End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. India End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Australia End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
Figure 74. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
Figure 75. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
Figure 76. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
Figure 77. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Share by Country (2017-2028)
Figure 78. Latin America End-Stage Renal Disease (ESRD) Drugs Revenue Share by Country (2017-2028)
Figure 79. Mexico End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue Share by Country (2017-2028)
Figure 88. Turkey End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. UAE End-Stage Renal Disease (ESRD) Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. End-Stage Renal Disease (ESRD) Drugs Value Chain
Figure 92. End-Stage Renal Disease (ESRD) Drugs Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Industry Market Size
